Exclusive: Bio-Techne Executive On M&A Possiblities By: Benzinga via Benzinga July 16, 2014 at 10:59 AM EDT Bio-Techne (NASDAQ: TECH) announced the $60 million acquisition of Novus Biologicals earlier this month and the $300 million acquisition ... Read More >> Related Stocks: General Electric Macy's Thermo Fisher Scientific